Back

Clinical impact of serum cholinesterase level on clinical outcomes in patients with lower extremity artery disease undergoing endovascular treatment

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Peripheral artery disease: endovascular and open treatments Peripheral Artery Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Hirokazu Shimono

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima (Japan)

7 More presentations in this session

Presentation thumbnail
Patient and procedural characteristics of successful endovascular procedures in the BEST-CLI Trial and their relationship to major adverse limb events
Associate Professor S. Kinlay (Boston, US)
Abstract Slides Video
Presentation thumbnail
Impact of the lower extremity arterial calcification score on clinical outcomes after drug-coated balloon angioplasty for de novo femoropopliteal artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of low-dose versus high-dose paclitaxel-coated balloons in patients with femoropopliteal lesions: an updated and meta-analysis.
Doctor M. Desouki (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Preclinical assessment of transcatheter-delivered expandable endoluminal polymeric graft fabricated by electrospinning of microfiber
Doctor K. Miyashita (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Factors affecting in-hospital clinical outcomes in patients with acute limb ischemia undergoing endovascular therapy or fogarty thrombectomy: a large-scale analysis based on the JROAD-DPC database
Doctor T. Ozawa (Kyoto, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: endovascular and open treatments

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
A predictors for 10-year mortality and clinical events in patients with chronic coronary total occlusion lesion
thumbnail
Congress Presentation
Impact of worsening renal function (WRF) and baseline chronic kidney disease (CKD) on clinical outcomes in patients with chronic coronary syndromes (CCS); insights from the REAL-CAD study
thumbnail
Congress Presentation
Long-term prognostic implications of pericoronary inflammation assessed by pre-interventional computed tomography in patients with non-ST-segment elevation acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources